<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Bee, yellow jacket, wasp, and other Hymenoptera stings: Reaction types and acute management
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Bee, yellow jacket, wasp, and other Hymenoptera stings: Reaction types and acute management
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Bee, yellow jacket, wasp, and other Hymenoptera stings: Reaction types and acute management
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Theodore Freeman, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            David BK Golden, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Anna M Feldweg, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jan 25, 2024.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H531245643">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Hymenoptera species that sting humans include bees, wasps, yellow jackets, hornets, and imported fire ants. Most people develop only minor local reactions, but patients with venom allergy are at risk for systemic allergic reactions (ie, anaphylaxis), which can be particularly severe and are a leading cause of anaphylaxis fatalities. There are also several uncommon and delayed types of reactions that may develop after Hymenoptera stings, such as serum sickness.
        </p>
        <p>
         This topic reviews the types of reactions that result from Hymenoptera stings, including local reactions and systemic allergic reactions, and the acute management of each. The diagnosis and long-term management of Hymenoptera allergy are presented separately. (See
         <a class="medical medical_review" href="/z/d/html/4095.html" rel="external">
          "Diagnosis of Hymenoptera venom allergy"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4090.html" rel="external">
          "Hymenoptera venom immunotherapy: Efficacy, indications, and mechanism of action"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1">
         <span class="h1">
          OVERVIEW
         </span>
         <span class="headingEndMark">
          —
         </span>
         The insects that are responsible for the majority of serious sting-related reactions belong to the order Hymenoptera. The
        </p>
        <p class="headingAnchor" id="H1762872123">
         <span class="h2">
          Stinging Hymenoptera
         </span>
         <span class="headingEndMark">
          —
         </span>
         Hymenoptera families of medical interest include the following [
         <a href="#rid1">
          1-3
         </a>
         ]:
        </p>
        <p>
         The winged Hymenoptera:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Apidae family (honey bees  (
         <a class="graphic graphic_picture graphicRef79579" href="/z/d/graphic/79579.html" rel="external">
          picture 1
         </a>
         ) and bumble bees).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Vespidae family (yellow jackets  (
         <a class="graphic graphic_picture graphicRef79706" href="/z/d/graphic/79706.html" rel="external">
          picture 2
         </a>
         ), yellow hornets, white-faced hornets, and paper wasps  (
         <a class="graphic graphic_picture graphicRef70439" href="/z/d/graphic/70439.html" rel="external">
          picture 3
         </a>
         )).
        </p>
        <p>
        </p>
        <p>
         The wingless Hymenoptera:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Formicidae family (fire ants  (
         <a class="graphic graphic_picture graphicRef82396" href="/z/d/graphic/82396.html" rel="external">
          picture 4
         </a>
         ), harvester ants, bulldog ants, and jack jumper ants). The clinical manifestations and treatment of fire ant stings are discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/4092.html" rel="external">
          "Stings of imported fire ants: Clinical manifestations, diagnosis, and treatment"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         Hymenoptera generally sting people in self-defense or to protect their nests or hives. Their stings are acutely painful, and patients are aware that a sting has occurred, although they may not have visualized the insect. Identification of the responsible winged Hymenoptera species can be difficult since the resultant lesions are similar in appearance. A culprit species can sometimes be identified based upon nest location and appearance, geographic location, or setting in which the sting occurred. (See
         <a class="medical medical_review" href="/z/d/html/4093.html" rel="external">
          "Stinging insects: Biology and identification"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H531249095">
         <span class="h2">
          Insect and stinger removal
         </span>
         <span class="headingEndMark">
          —
         </span>
         Bees (and occasionally yellow jackets) have a barbed stinging apparatus that becomes lodged in the skin and rips away, along with the venom sac, from the insect's body following a sting event. The venom is released within the first several seconds after the sting [
         <a href="#rid4">
          4
         </a>
         ], so if the insect or stinger can be flicked off of the skin immediately, it may help limit the amount of venom injected. However, if the patient presents minutes later, immediate stinger removal is not critical, because the venom will have already been fully expelled. Remaining stingers should eventually be removed because they can occasionally cause foreign body reactions [
         <a href="#rid5">
          5,6
         </a>
         ].
        </p>
        <p>
         Imported fire ants grasp the skin firmly with their mandibles and inflict multiple stings per insect, so these should be promptly removed as well.
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h1">
          LOCAL REACTIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Local reactions consist of symptoms that are confined to the tissues contiguous with the sting site. They are usually mild and transient, although some patients develop large local reactions (LLRs) or (rarely) secondary bacterial infections.
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h2">
          Uncomplicated local reactions
         </span>
         <span class="headingEndMark">
          —
         </span>
         A typical local reaction to a Hymenoptera sting is redness and an area of painful swelling (1 to 5 cm) at the site of the sting that develops within minutes and resolves within a few hours  (
         <a class="graphic graphic_picture graphicRef81060" href="/z/d/graphic/81060.html" rel="external">
          picture 5
         </a>
         ). Occasionally, swelling may last one to two days. Uncomplicated local reactions may be treated with cold compresses.
        </p>
        <p>
         Imported fire ant stings typically cause pustule-like lesions at the site of the sting(s) within about 24 hours  (
         <a class="graphic graphic_picture graphicRef76841" href="/z/d/graphic/76841.html" rel="external">
          picture 6
         </a>
         ) [
         <a href="#rid7">
          7
         </a>
         ]. These pseudopustules are sterile, and patients should be advised not to open them, as this can lead to infection. In the absence of this advice, patients tend to unroof the lesions, either because of the intense pruritus associated with fire ant stings or because conventional wisdom dictates "draining the infection" [
         <a href="#rid8">
          8
         </a>
         ]. Additional measures for the care of local reactions to fire ant stings are presented elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/4092.html" rel="external">
          "Stings of imported fire ants: Clinical manifestations, diagnosis, and treatment"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h2">
          Large local reactions
         </span>
         <span class="headingEndMark">
          —
         </span>
         Approximately 10 percent of individuals develop exaggerated redness and swelling at the site of the sting that gradually enlarges over one to two days  (
         <a class="graphic graphic_picture graphicRef97002" href="/z/d/graphic/97002.html" rel="external">
          picture 7
         </a>
         ). This response is called a large local reaction (LLR). LLRs peak at approximately 48 hours and then gradually resolve over 5 to 10 days. The area of swelling typically measures about 10 cm in diameter [
         <a href="#rid9">
          9,10
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h3">
          Treatment
         </span>
         <span class="headingEndMark">
          —
         </span>
         Treatment of LLRs is based upon symptoms. We know of no published studies comparing different treatments. Our approach is described below:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cold compresses are soothing acutely. The limb should be elevated if the sting is on an extremity.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Oral
         <a class="drug drug_general" data-topicid="9809" href="/z/d/drug information/9809.html" rel="external">
          prednisone
         </a>
         40 to 60 mg given as a single dose or rapidly tapered over two to five days may help reduce significant swelling.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         If the reaction is painful, nonsteroidal antiinflammatory drugs (NSAIDs) can be helpful.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Pruritus can be treated with oral antihistamines (eg,
         <a class="drug drug_general" data-topicid="9236" href="/z/d/drug information/9236.html" rel="external">
          cetirizine
         </a>
         , 10 mg once daily) and high-potency topical corticosteroids (eg,
         <a class="drug drug_general" data-topicid="8460" href="/z/d/drug information/8460.html" rel="external">
          fluocinonide
         </a>
         0.05% or
         <a class="drug drug_general" data-topicid="9276" href="/z/d/drug information/9276.html" rel="external">
          clobetasol
         </a>
         0.05% ointment, applied every four hours) until the itching subsides.
        </p>
        <p>
        </p>
        <p>
         Hymenoptera stings are considered "clean" for the purposes of tetanus vaccination. Stings are very superficial, and there are no published reports of tetanus infection following Hymenoptera stings. A tetanus booster is not necessary following a sting unless there was a concomitant soil-contaminated injury. (See
         <a class="medical medical_review" href="/z/d/html/3897.html" rel="external">
          "Tetanus-diphtheria toxoid vaccination in adults", section on 'Immunization for patients with injuries'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h3">
          Excluding a secondary bacterial infection
         </span>
         <span class="headingEndMark">
          —
         </span>
         Most Hymenoptera stings do not become superinfected, although this can occur. An infected sting must be differentiated from an LLR. (See
         <a class="local">
          'Large local reactions'
         </a>
         above.)
        </p>
        <p>
         Infection is suspected when redness, swelling, and pain become dramatically worse three to five days after the sting, when the typical LLR is beginning to regress. The presence of fever suggests infection, but lymphangitis streaks may be seen with either infection or an uncomplicated LLR. If the clinician is unsure, a course of oral antibiotics may be prudent. (See
         <a class="medical medical_review" href="/z/d/html/110530.html" rel="external">
          "Acute cellulitis and erysipelas in adults: Treatment"
         </a>
         .)
        </p>
        <p>
         The stings of yellow jackets and imported fire ants are more likely to become infected than those of other species [
         <a href="#rid11">
          11
         </a>
         ]. Yellow jackets tend to scavenge around rotting food and presumably carry bacteria on their exterior. Fire ant stings cause sterile pustule-like lesions that can become infected if opened.
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h3">
          Future risk of systemic reactions
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with a history of an LLR most often have the same response to subsequent stings [
         <a href="#rid12">
          12,13
         </a>
         ]. It is not known if the risk of recurrent LLRs changes over time or is influenced by the frequency of stings.
        </p>
        <p>
         The risk for a systemic allergic reaction after an LLR has been estimated at approximately 7 percent (4 to 10 percent), based on observational studies [
         <a href="#rid14">
          14
         </a>
         ]. However, the risk of moderate or severe anaphylaxis is lower and estimated at &lt;3 percent. Most of the subsequent reactions that are more severe than LLRs are still limited to the skin (generalized urticaria and angioedema) and are called cutaneous systemic reactions. (See
         <a class="medical medical_review" href="/z/d/html/4090.html" rel="external">
          "Hymenoptera venom immunotherapy: Efficacy, indications, and mechanism of action", section on 'Patients with past cutaneous systemic reactions'
         </a>
         .)
        </p>
        <p>
         However, a 2019 prospective study of over 600 patients with an LLR from three European countries found a significantly higher rate of systemic reactions (16 percent) among the 225 patients who reported subsequent stings, including 11 percent that were serious [
         <a href="#rid15">
          15
         </a>
         ]. In this population, a positive intradermal skin test at a low venom concentration (0.001 ug/L) correlated with a higher risk of subsequent systemic reaction. Because these findings are so different from the existing understanding of the natural history of LLRs, both the investigators and the author and editor of this topic emphasize the need for replication in other populations and study designs before changing practice.
        </p>
        <p>
         Until more data are available, we suggest that patients with a history of an LLR, similar to those with cutaneous systemic reactions, be advised that the chance of future anaphylaxis is relatively low and that current guidelines do not require
         <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">
          epinephrine
         </a>
         autoinjectors or VIT. However, the guidelines also provide that patients who are uncomfortable with the uncertainty surrounding future risk of a systemic reaction or who have other risk factors may be offered an epinephrine autoinjector prescription and referred to an allergist for further discussion. Note that there is some evidence that being told to carry an epinephrine autoinjector is associated with a decrease in quality of life, so the decision must be individualized [
         <a href="#rid16">
          16
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H30381667">
         <span class="h3">
          Pathogenesis
         </span>
         <span class="headingEndMark">
          —
         </span>
         LLRs are believed to be immunoglobulin E (IgE)-mediated based upon the following evidence:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The frequency of positive venom skin tests or venom-specific serum IgE is the same in patients with LLRs as in those with anaphylactic reactions [
         <a href="#rid12">
          12
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In one patient, large local reactivity to fire ant stings was transferred passively (using the Prausnitz-Kustner reaction) [
         <a href="#rid17">
          17
         </a>
         ]. Also in this report, eosinophils, which are found in the late phase of IgE-mediated allergic reactions, were demonstrated in biopsy specimens from patients with fire ant-induced LLRs but not in specimens from patients without LLRs.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Both sting-induced anaphylaxis and LLRs can be treated with venom immunotherapy, a technique classically applied to IgE-mediated reactions. Although most patients with LLRs are not treated with venom immunotherapy, treatment can be considered for those wishing to lower the risk of future anaphylaxis further or who have frequent stings and wish to take measures to reduce the severity of future LLRs (and the need for glucocorticoid treatment). The indications for venom immunotherapy are reviewed in more detail separately. (See
         <a class="medical medical_review" href="/z/d/html/4090.html" rel="external">
          "Hymenoptera venom immunotherapy: Efficacy, indications, and mechanism of action"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         The reason that patients with past LLRs are at low risk for future anaphylaxis while those with past systemic allergic reactions are at high risk, when both reactions appear to be IgE-mediated, is unknown.
        </p>
        <p class="headingAnchor" id="H531245181">
         <span class="h3">
          Prevention
         </span>
         <span class="headingEndMark">
          —
         </span>
         Some individuals develop predictable LLRs with every Hymenoptera sting and seek advice on how to prevent this. Our clinical experience is that administration of a single dose of 20 to 60 mg of
         <a class="drug drug_general" data-topicid="9809" href="/z/d/drug information/9809.html" rel="external">
          prednisone
         </a>
         (depending upon the historical severity of the LLR) within two hours of the sting often attenuates the response.
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h1">
          SYSTEMIC ALLERGIC REACTIONS/ANAPHYLAXIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The most dangerous immediate reaction to Hymenoptera stings is a systemic allergic reaction, or anaphylaxis (the terms are used interchangeably in this review). Anaphylaxis may be defined as a serious allergic reaction that is rapid in onset and may cause death [
         <a href="#rid18">
          18
         </a>
         ]. Venom-induced anaphylaxis involves signs and symptoms in one or more anatomic systems distant from the site of the sting.
        </p>
        <p>
         A single sting is sufficient to precipitate a severe reaction in a venom-allergic individual, and insect stings are a leading cause of fatal anaphylaxis [
         <a href="#rid19">
          19
         </a>
         ]. Venom-induced anaphylaxis can be particularly severe, sometimes persisting despite multiple doses of
         <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">
          epinephrine
         </a>
         [
         <a href="#rid20">
          20,21
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h2">
          Epidemiology of venom anaphylaxis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Anaphylaxis is reported in 0.3 to 3 percent of stings [
         <a href="#rid18">
          18,22,23
         </a>
         ], affecting up to 8 percent of some populations [
         <a href="#rid24">
          24,25
         </a>
         ]. Hymenoptera stings cause at least 40 identified deaths annually in the United States, and reported rates are similar in other parts of the world [
         <a href="#rid24">
          24,26,27
         </a>
         ]. The true incidence of fatal reactions may be higher because sudden deaths occurring outdoors may be mistakenly attributed to heart attacks or strokes. One study found a high frequency of venom-specific immunoglobulin E (IgE) in the postmortem serum of individuals who had died suddenly of unknown cause [
         <a href="#rid28">
          28
         </a>
         ]. Even more suspicious is the presence of both elevated serum tryptase (a mediator that is released from mast cells and basophils during anaphylaxis) and venom IgE in deaths of unknown cause [
         <a href="#rid29">
          29
         </a>
         ]. The utility of tryptase measurements in the postmortem diagnosis of anaphylaxis is reviewed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/389.html" rel="external">
          "Laboratory tests to support the clinical diagnosis of anaphylaxis"
         </a>
         .)
        </p>
        <p>
         An American survey study of the general population found that approximately 3 percent of people reported experiencing some systemic symptom after a Hymenoptera sting [
         <a href="#rid30">
          30
         </a>
         ]. Since approximately 60 to 90 percent of patients with a suggestive clinical history have venom-specific IgE upon evaluation, an estimated 2 percent of the adult population (and 0.5 percent of children) could have venom allergy.
        </p>
        <p>
         About one-half of patients who die as a result of Hymenoptera-induced anaphylaxis did not know that they had an allergy [
         <a href="#rid24">
          24,31
         </a>
         ]. In the survey mentioned previously, the majority of patients who reported past systemic symptoms had not sought medical attention. Thus, venom allergy is very likely under-recognized and underdiagnosed.
        </p>
        <p>
         Venom allergy can develop at any age, but adults suffer more severe reactions, and most deaths occur in this age group. Men are affected more often than women, probably due to a greater prevalence of outdoor occupations [
         <a href="#rid19">
          19,31
         </a>
         ]. Not surprisingly, beekeepers are at highest risk [
         <a href="#rid32">
          32
         </a>
         ].
        </p>
        <p>
         Patients with concomitant cardiovascular disease and a poor tolerance for biochemical and physiologic stress are at particular risk for severe and fatal anaphylaxis [
         <a href="#rid33">
          33-35
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/390.html" rel="external">
          "Fatal anaphylaxis"
         </a>
         .)
        </p>
        <p>
         One to 2 percent of patients with severe anaphylactic reactions following Hymenoptera stings are subsequently found to have clonal mast cell disease (eg, cutaneous and systemic mastocytosis, as well as other clonal mast cell disorders) [
         <a href="#rid36">
          36-38
         </a>
         ]. These patients may have a characteristic dermatitis called urticaria pigmentosa  (
         <a class="graphic graphic_picture graphicRef63025" href="/z/d/graphic/63025.html" rel="external">
          picture 8
         </a>
         ) or report a history of multiple allergic reactions to various triggers. (See
         <a class="medical medical_review" href="/z/d/html/103161.html" rel="external">
          "Mastocytosis (cutaneous and systemic) in children: Epidemiology, clinical manifestations, evaluation, and diagnosis", section on 'Allergic disorders'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4784.html" rel="external">
          "Mastocytosis (cutaneous and systemic) in adults: Epidemiology, pathogenesis, clinical manifestations, and diagnosis", section on 'Introduction'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h2">
          Signs and symptoms
         </span>
         <span class="headingEndMark">
          —
         </span>
         When evaluating a patient with any symptoms of an allergic reaction, it is important to ask specifically about the different manifestations of anaphylaxis, as patients often focus on just one symptom and do not recognize other symptoms or may not report sensations with which they are unfamiliar and cannot readily describe. Sudden illness on the golf course or while working in the yard may be readily mistaken for a cardiovascular event or asthma attack, unless the patient is carefully questioned/examined to reveal the full array of signs and symptoms [
         <a href="#rid29">
          29
         </a>
         ].
        </p>
        <p>
         There are over 40 signs and symptoms of anaphylaxis  (
         <a class="graphic graphic_table graphicRef66333" href="/z/d/graphic/66333.html" rel="external">
          table 1
         </a>
         ). In venom-induced anaphylaxis, the following are regularly reported:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Skin symptoms, such as generalized urticaria, flushing, and angioedema, are common. This is the sole manifestation of a systemic allergic reaction in the majority of children (ie, about 60 percent). In contrast, only about 15 percent of adults with systemic reactions develop isolated cutaneous symptoms [
         <a href="#rid39">
          39
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Respiratory symptoms include hoarse voice or upper airway obstruction due to edema of the pharynx and epiglottis and shortness of breath and wheezing due to bronchoconstriction.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cardiovascular symptoms, ranging from lightheadedness to hypotension, shock, and circulatory collapse, are features of severe sting anaphylaxis [
         <a href="#rid27">
          27,31,40
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         Adults tend to have more severe systemic reactions, and the vast majority of deaths occur in adults as a result of circulatory collapse. Ninety percent of adults have reactions involving the respiratory or cardiovascular system, whereas only 30 percent of reactions in children demonstrate cardiopulmonary symptoms [
         <a href="#rid21">
          21
         </a>
         ]. In adults, the absence of cutaneous manifestations is associated with more severe reactions [
         <a href="#rid40">
          40
         </a>
         ].
        </p>
        <p>
         Most episodes of venom anaphylaxis develop rapidly, and the precipitous appearance of symptoms is a feature of severe reactions. One study in adults identified the onset of symptoms within five minutes of the sting as a feature of severe anaphylaxis [
         <a href="#rid40">
          40
         </a>
         ]. Typically, symptoms initially escalate and then resolve in a uniphasic manner. However, a small percentage follows a biphasic course, in which the initial reaction is treated and resolves or resolves spontaneously, but there is a recurrence of symptoms hours later [
         <a href="#rid24">
          24
         </a>
         ]. Protracted anaphylaxis is another uncommon presentation [
         <a href="#rid39">
          39
         </a>
         ]. The clinical manifestations and temporal patterns of anaphylaxis from all causes are reviewed separately. (See
         <a class="medical medical_review" href="/z/d/html/392.html" rel="external">
          "Anaphylaxis: Emergency treatment"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h2">
          Diagnosis and laboratory findings
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diagnosis of anaphylaxis is clinical and based upon signs and symptoms in the setting of a suggestive history. Three diagnostic criteria have been proposed, each reflecting a different clinical presentation of anaphylaxis  (
         <a class="graphic graphic_table graphicRef72225" href="/z/d/graphic/72225.html" rel="external">
          table 2
         </a>
         ) [
         <a href="#rid18">
          18
         </a>
         ]. Anaphylaxis is highly likely when
         <strong>
          any one
         </strong>
         criterion is fulfilled. The diagnosis can be particularly challenging when cardiovascular signs and symptoms exist in isolation (eg, criterion 3). (See
         <a class="medical medical_review" href="/z/d/html/392.html" rel="external">
          "Anaphylaxis: Emergency treatment"
         </a>
         .)
        </p>
        <p>
         The diagnosis of anaphylaxis can be further supported by the documentation of elevated concentrations of the mast cell and basophil mediators' histamine or total tryptase. Any elevation is consistent with anaphylaxis and indicates that these cells have been activated on a massive scale. These changes may be very transient, and normal levels do not exclude the diagnosis. It is critical to obtain blood samples for measurement of these mediators during specific windows of time after the onset of symptoms. Instructions for proper timing and collection of samples are provided  (
         <a class="graphic graphic_table graphicRef72041" href="/z/d/graphic/72041.html" rel="external">
          table 3
         </a>
         ). The interpretation of elevations in histamine and tryptase are reviewed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/389.html" rel="external">
          "Laboratory tests to support the clinical diagnosis of anaphylaxis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h2">
          Acute management
         </span>
         <span class="headingEndMark">
          —
         </span>
         Acute management of venom-induced anaphylaxis is similar to the treatment of anaphylaxis from other causes, with intramuscular injection of
         <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">
          epinephrine
         </a>
         into the anterolateral thigh being the initial drug of choice.
        </p>
        <p>
         Rapid overview tables of the initial assessment and treatment of anaphylaxis and dosing of
         <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">
          epinephrine
         </a>
         in adults  (
         <a class="graphic graphic_table graphicRef58346" href="/z/d/graphic/58346.html" rel="external">
          table 4
         </a>
         ) and children  (
         <a class="graphic graphic_table graphicRef74242" href="/z/d/graphic/74242.html" rel="external">
          table 5
         </a>
         ) are provided. These tables are intended to assist clinicians in emergency department and urgent care settings. Anaphylaxis management is discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/392.html" rel="external">
          "Anaphylaxis: Emergency treatment", section on 'Immediate management'
         </a>
         .)
        </p>
        <p>
         The treatment of widespread urticaria, which represents a generalized reaction but does not meet criteria for anaphylaxis, is influenced in part by the patient's age.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In children under 16 years of age, in whom generalized cutaneous reactions are more common and do not predictably progress to anaphylaxis, treatment with
         <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">
          epinephrine
         </a>
         need not be given for widespread urticaria. However, epinephrine should be given without delay if the child has symptoms beyond the skin or a history of past sting-induced anaphylaxis. (See
         <a class="local">
          'Natural history of systemic allergic reactions'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In contrast,
         <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">
          epinephrine
         </a>
         may be administered to adults with widespread urticaria, as venom reactions can be more severe in this age group. However, use of epinephrine might not be necessary if the patient had a history of other past reactions limited to urticaria.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h2">
          Discharge care and referral
         </span>
         <span class="headingEndMark">
          —
         </span>
         Prior to discharge from the acute care setting, patients should be informed that venom allergy is a potentially fatal disorder, further evaluation will be needed, and that venom immunotherapy is available to prevent anaphylaxis to future stings.
        </p>
        <p>
         They should receive:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         An
         <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">
          epinephrine
         </a>
         autoinjector(s) (supplying at least two doses of epinephrine)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Instructions on how and when to use
         <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">
          epinephrine
         </a>
         (see
         <a class="medical medical_basics" href="/z/d/html/15917.html" rel="external">
          "Patient education: How to use an epinephrine autoinjector (The Basics)"
         </a>
         and
         <a class="medical medical_patient" href="/z/d/html/365.html" rel="external">
          "Patient education: Using an epinephrine autoinjector (Beyond the Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Clear directions to fill the prescription immediately and carry
         <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">
          epinephrine
         </a>
         at all times
        </p>
        <p>
        </p>
        <p>
         Discharge care for patients with anaphylaxis is reviewed in more detail separately. (See
         <a class="medical medical_review" href="/z/d/html/392.html" rel="external">
          "Anaphylaxis: Emergency treatment", section on 'Discharge care'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/388.html" rel="external">
          "Prescribing epinephrine for anaphylaxis self-treatment"
         </a>
         .)
        </p>
        <p>
         Patients suspected of having a systemic allergic reaction following a Hymenoptera sting (of any severity) should be referred to an allergist/immunologist to determine if they are candidates for venom immunotherapy [
         <a href="#rid10">
          10
         </a>
         ]. Providing the patient with a prescription for self-injectable
         <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">
          epinephrine
         </a>
         is an essential but not sufficient intervention because patients often do not fill the prescription or have the epinephrine on hand when needed and because severe venom anaphylaxis can be refractory even to promptly administered epinephrine [
         <a href="#rid21">
          21
         </a>
         ]. Venom immunotherapy reduces the risk of recurrent life-threatening reactions from 30 to 60 percent to less than 5 percent and is the definitive treatment for venom allergy. (See
         <a class="medical medical_review" href="/z/d/html/4090.html" rel="external">
          "Hymenoptera venom immunotherapy: Efficacy, indications, and mechanism of action"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H16">
         <span class="h2">
          Natural history of systemic allergic reactions
         </span>
         <span class="headingEndMark">
          —
         </span>
         In patients with confirmed venom allergy who are not treated with venom immunotherapy, the risk of anaphylaxis to a subsequent sting is approximately 30 to 60 percent [
         <a href="#rid41">
          41
         </a>
         ]. Subsequent reactions tend to be of similar or lesser intensity. Less than 10 percent of patients had a more severe reaction on subsequent stings in one series [
         <a href="#rid41">
          41
         </a>
         ]. The impact of venom immunotherapy on the risk of a recurrent systemic reaction is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/4090.html" rel="external">
          "Hymenoptera venom immunotherapy: Efficacy, indications, and mechanism of action"
         </a>
         .)
        </p>
        <p>
         Patients with symptoms limited to the skin (eg, urticaria and/or angioedema, even if widespread) are at low risk for future more severe systemic reactions. Children under 16 years of age, specifically, have about a 10 percent chance of future systemic reactions, most of which will also be limited to the skin [
         <a href="#rid14">
          14
         </a>
         ]. The risk in adults is similarly low but not as well-defined [
         <a href="#rid10">
          10
         </a>
         ]. The reasons for this lack of progression over time are not clear.
        </p>
        <p class="headingAnchor" id="H18">
         <span class="h1">
          OTHER UNUSUAL REACTIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Rarely, toxic effects are seen with large numbers of simultaneous stings. In addition, Hymenoptera stings occasionally cause delayed-onset, immunologic or idiosyncratic reactions, such as serum sickness or nephritis.
        </p>
        <p class="headingAnchor" id="H19">
         <span class="h2">
          Toxic reactions from numerous stings
         </span>
         <span class="headingEndMark">
          —
         </span>
         The venoms injected by Hymenoptera are toxic and have vasoactive properties that are associated with systemic symptoms. Symptoms include nausea, vomiting, diarrhea, headache, vertigo, syncope, convulsions, and fever. Hemolysis, cardiac complications, renal failure, and rhabdomyolysis have also been described [
         <a href="#rid42">
          42,43
         </a>
         ].
        </p>
        <p>
         Massive numbers of fire ant stings have been reported in infants and debilitated older adults who could not defend themselves or escape. The evaluation and treatment of such patients is discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/4092.html" rel="external">
          "Stings of imported fire ants: Clinical manifestations, diagnosis, and treatment", section on 'Massive attacks'
         </a>
         .)
        </p>
        <p>
         Toxic reactions are uncommon, since most stinging events involve one to a few stings, and only a small amount of toxin is injected into the body [
         <a href="#rid42">
          42
         </a>
         ]. However, patients who disrupt a nest or hive can sustain massive envenomation as the insects swarm out in defense. Case reports of toxic reactions mostly involved patients who had sustained hundreds of stings, although renal failure has been described after as few as 20 wasp stings [
         <a href="#rid31">
          31,42
         </a>
         ]. The number of stings associated with a potential 50 percent fatality rate due to direct venom effects (ie, the LD50) has been calculated (based upon animal models) to be 1500 stings for a 75-kg individual [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p>
         Africanized honey bees, found in South America and the southwestern United States, are no more toxic per sting than other bees [
         <a href="#rid44">
          44,45
         </a>
         ]. However, this species acquired the common name "killer bees" because they can sting in large numbers once provoked [
         <a href="#rid46">
          46
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H20">
         <span class="h3">
          Acute treatment
         </span>
         <span class="headingEndMark">
          —
         </span>
         Acute treatment of a patient with numerous Hymenoptera stings begins with rapid general assessment and prompt removal of any insects entrapped in the patient's clothing, so that additional stings are prevented.
        </p>
        <p>
         Clinical symptoms dictate pharmacologic management. There are no specific antitoxins available for the treatment of Hymenoptera stings. Some patients have concomitant anaphylaxis and require immediate
         <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">
          epinephrine
         </a>
         and other appropriate management [
         <a href="#rid43">
          43
         </a>
         ]. Otherwise, care is supportive. The patient should be observed and monitored with serial chemistries, including hemoglobin and myoglobin [
         <a href="#rid42">
          42
         </a>
         ].
        </p>
        <p>
         Insect venom is highly sensitizing, and individuals who have sustained a toxic reaction after multiple stings may develop positive skin tests to venoms and are at risk for anaphylactic reactions in response to future stings. Referral to an allergy specialist is indicated.
        </p>
        <p class="headingAnchor" id="H21">
         <span class="h2">
          Other uncommon reactions
         </span>
         <span class="headingEndMark">
          —
         </span>
         Occasionally, other types of systemic reactions are reported after insect stings. These include serum sickness, vasculitis, neuritis, myocarditis, and encephalitis [
         <a href="#rid10">
          10,47-49
         </a>
         ]. Onset is typically delayed by days to weeks after the sting, as most of these reactions arise from the tissue deposition of antibody-antigen complexes, which precipitate only after sufficient antibody has been formed.
        </p>
        <p>
         As an example, serum sickness is usually manifested as urticaria with joint pain, fever, fatigue, and lymphadenopathy 7 to 10 days after the sting [
         <a href="#rid47">
          47
         </a>
         ]. Patients with serum sickness may demonstrate immunoglobulin E (IgE) and immunoglobulin G (IgG) antivenom antibodies [
         <a href="#rid50">
          50
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2078.html" rel="external">
          "Serum sickness and serum sickness-like reactions"
         </a>
         .)
        </p>
        <p>
         The development of cold-induced urticaria has also been noted, beginning days to weeks after Hymenoptera stings [
         <a href="#rid51">
          51-53
         </a>
         ]. Most patients had no adverse reaction to the sting itself.
        </p>
        <p class="headingAnchor" id="H979116338">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/108971.html" rel="external">
          "Society guideline links: Stinging insect allergy"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H26909792">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topics (see
         <a class="medical medical_basics" href="/z/d/html/15336.html" rel="external">
          "Patient education: Anaphylaxis (The Basics)"
         </a>
         and
         <a class="medical medical_basics" href="/z/d/html/15917.html" rel="external">
          "Patient education: How to use an epinephrine autoinjector (The Basics)"
         </a>
         and
         <a class="medical medical_basics" href="/z/d/html/15338.html" rel="external">
          "Patient education: Insect bites and stings (The Basics)"
         </a>
         and
         <a class="medical medical_basics" href="/z/d/html/82903.html" rel="external">
          "Patient education: Insect allergy (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Beyond the Basics topics (see
         <a class="medical medical_patient" href="/z/d/html/368.html" rel="external">
          "Patient education: Anaphylaxis symptoms and diagnosis (Beyond the Basics)"
         </a>
         and
         <a class="medical medical_patient" href="/z/d/html/372.html" rel="external">
          "Patient education: Anaphylaxis treatment and prevention of recurrences (Beyond the Basics)"
         </a>
         and
         <a class="medical medical_patient" href="/z/d/html/365.html" rel="external">
          "Patient education: Using an epinephrine autoinjector (Beyond the Basics)"
         </a>
         and
         <a class="medical medical_patient" href="/z/d/html/383.html" rel="external">
          "Patient education: Bee and insect stings (Beyond the Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H22">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Stinging insects
         </strong>
         – Bees, wasps, yellow jackets, hornets, and imported fire ants are all members of the order Hymenoptera. (See
         <a class="local">
          'Stinging Hymenoptera'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Uncomplicated local reactions
         </strong>
         – The most common reaction to Hymenoptera stings is transient pain and redness at the sting site lasting a few hours (local reaction)  (
         <a class="graphic graphic_picture graphicRef81060" href="/z/d/graphic/81060.html" rel="external">
          picture 5
         </a>
         ). Local reactions usually do not require treatment. Application of cold compresses can be helpful. (See
         <a class="local">
          'Local reactions'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Large local reactions
         </strong>
         – Large local reactions (LLRs) consist of exaggerated swelling lasting a few days  (
         <a class="graphic graphic_picture graphicRef97002" href="/z/d/graphic/97002.html" rel="external">
          picture 7
         </a>
         ). LLRs typically require symptomatic treatment to control itching (most prominent with fire ant stings) or minimize swelling. The affected part should be elevated if possible. For severe swelling, we suggest administration of oral
         <a class="drug drug_general" data-topicid="9809" href="/z/d/drug information/9809.html" rel="external">
          prednisone
         </a>
         (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). A dose of 20 to 60 mg given once or tapered rapidly over two to five days is sufficient. (See
         <a class="local">
          'Treatment'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Anaphylaxis
         </strong>
         – Anaphylaxis occurs in up to 3 percent of stings due to allergens in Hymenoptera venoms. Venom-induced anaphylaxis can be particularly severe and is a leading cause of anaphylactic deaths. Anaphylaxis is diagnosed clinically  (
         <a class="graphic graphic_table graphicRef72225" href="/z/d/graphic/72225.html" rel="external">
          table 2
         </a>
         ). Individuals with possible allergy should be questioned carefully about the different symptoms of anaphylaxis, which may be unfamiliar to the patient and not readily reported  (
         <a class="graphic graphic_table graphicRef66333" href="/z/d/graphic/66333.html" rel="external">
          table 1
         </a>
         ). (See
         <a class="local">
          'Systemic allergic reactions/anaphylaxis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Treatment of anaphylaxis
         </strong>
         – The initial treatment of choice for anaphylaxis is
         <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">
          epinephrine
         </a>
         injected intramuscularly into the anterolateral thigh  (
         <a class="graphic graphic_table graphicRef58346" href="/z/d/graphic/58346.html" rel="external">
          table 4
         </a>
         and
         <a class="graphic graphic_table graphicRef74242" href="/z/d/graphic/74242.html" rel="external">
          table 5
         </a>
         ). (See
         <a class="local">
          'Acute management'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          After care and referral for venom immunotherapy
         </strong>
         – Upon discharge, any patient with symptoms of a systemic allergic reaction or anaphylaxis should receive both of the following:
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         An
         <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">
          epinephrine
         </a>
         autoinjector and instructions about how and when to use it. (See
         <a class="medical medical_basics" href="/z/d/html/15917.html" rel="external">
          "Patient education: How to use an epinephrine autoinjector (The Basics)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Referral to an allergy specialist to determine if he/she is a candidate for venom immunotherapy, which is the definitive treatment for venom allergy. Venom immunotherapy reduces the risk of a recurrent life-threatening reaction to a subsequent sting to less than 5 percent. Allergy specialists can also provide patients with detailed advice about strategies for avoidance. (See
         <a class="local">
          'Discharge care and referral'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Other rare reactions
         </strong>
         – Occasionally, large numbers of simultaneous stings may result in toxic reactions, which present with different combinations of nausea, vomiting, diarrhea, headache, vertigo, syncope, convulsions, and fever. Hemolysis, cardiac complications, renal failure, and rhabdomyolysis have also been reported. In addition, Hymenoptera stings occasionally cause delayed-onset, immunologic or idiosyncratic reactions, such as serum sickness, nephritis, or cold-induced urticaria. (See
         <a class="local">
          'Other unusual reactions'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li class="breakAll">
          Gurlanick MW, Benton AW. Entomological aspects of insect sting allergy. In: Monograph on insect allergy, 4th ed, Levine MI, Lockey RF (Eds), Dave Lambert Associates, Pittsburgh 2003. p.11.
         </li>
         <li class="breakAll">
          Goddard J. Physician's guide to arthropods of medical importance, 4th ed, CRC Press, Boca Raton 2003.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brown SG, Wiese MD, Blackman KE, Heddle RJ. Ant venom immunotherapy: a double-blind, placebo-controlled, crossover trial. Lancet 2003; 361:1001.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Visscher PK, Vetter RS, Camazine S. Removing bee stings. Lancet 1996; 348:301.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jain V, Shome D, Natarajan S. Corneal bee sting misdiagnosed as viral keratitis. Cornea 2007; 26:1277.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hur W, Ahn SK, Lee SH, Kang WH. Cutaneous reaction induced by retained bee stinger. J Dermatol 1991; 18:736.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tracy JM, Demain JG, Quinn JM, et al. The natural history of exposure to the imported fire ant (Solenopsis invicta). J Allergy Clin Immunol 1995; 95:824.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Triplett RF. The imported fire ant: health hazard or nuisance? South Med J 1976; 69:258.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Severino M, Bonadonna P, Passalacqua G. Large local reactions from stinging insects: from epidemiology to management. Curr Opin Allergy Clin Immunol 2009; 9:334.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Golden DB, Demain J, Freeman T, et al. Stinging insect hypersensitivity: A practice parameter update 2016. Ann Allergy Asthma Immunol 2017; 118:28.
          </a>
         </li>
         <li class="breakAll">
          Reisman RE. Clinical aspects of Hymenoptera allergy. In: Monograph on insect allergy, 4th ed, Levine MI, Lockey RF (Eds), Dave Lambert Associates, Pittsburgh 2003. p.55.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mauriello PM, Barde SH, Georgitis JW, Reisman RE. Natural history of large local reactions from stinging insects. J Allergy Clin Immunol 1984; 74:494.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Graft DF, Schuberth KC, Kagey-Sobotka A, et al. A prospective study of the natural history of large local reactions after Hymenoptera stings in children. J Pediatr 1984; 104:664.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Freeman TM. Clinical practice. Hypersensitivity to hymenoptera stings. N Engl J Med 2004; 351:1978.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bilò MB, Martini M, Pravettoni V, et al. Large local reactions to Hymenoptera stings: Outcome of re-stings in real life. Allergy 2019; 74:1969.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Oude Elberink JN, De Monchy JG, Van Der Heide S, et al. Venom immunotherapy improves health-related quality of life in patients allergic to yellow jacket venom. J Allergy Clin Immunol 2002; 110:174.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           deShazo RD, Griffing C, Kwan TH, et al. Dermal hypersensitivity reactions to imported fire ants. J Allergy Clin Immunol 1984; 74:841.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sampson HA, Muñoz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: summary report--Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 2006; 117:391.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tang ML, Osborne N, Allen K. Epidemiology of anaphylaxis. Curr Opin Allergy Clin Immunol 2009; 9:351.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hunt KJ, Valentine MD, Sobotka AK, et al. A controlled trial of immunotherapy in insect hypersensitivity. N Engl J Med 1978; 299:157.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smith PL, Kagey-Sobotka A, Bleecker ER, et al. Physiologic manifestations of human anaphylaxis. J Clin Invest 1980; 66:1072.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Graif Y, Romano-Zelekha O, Livne I, et al. Allergic reactions to insect stings: results from a national survey of 10,000 junior high school children in Israel. J Allergy Clin Immunol 2006; 117:1435.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Golden DB. Insect sting anaphylaxis. Immunol Allergy Clin North Am 2007; 27:261.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bilò BM, Bonifazi F. Epidemiology of insect-venom anaphylaxis. Curr Opin Allergy Clin Immunol 2008; 8:330.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Graft DF. Insect sting allergy. Med Clin North Am 2006; 90:211.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Valentine MD, Schuberth KC, Kagey-Sobotka A, et al. The value of immunotherapy with venom in children with allergy to insect stings. N Engl J Med 1990; 323:1601.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barnard JH. Studies of 400 Hymenoptera sting deaths in the United States. J Allergy Clin Immunol 1973; 52:259.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schwartz HJ, Squillace DL, Sher TH, et al. Studies in stinging insect hypersensitivity: postmortem demonstration of antivenom IgE antibody in possible sting-related sudden death. Am J Clin Pathol 1986; 85:607.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Riches KJ, Gillis D, James RA. An autopsy approach to bee sting-related deaths. Pathology 2002; 34:257.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Golden DB, Marsh DG, Kagey-Sobotka A, et al. Epidemiology of insect venom sensitivity. JAMA 1989; 262:240.
          </a>
         </li>
         <li class="breakAll">
          Levine MI, Nall TM. Pathologic findings in Hymenoptera sting fatalities. In: Monograph on insect allergy, 4th ed, Levine MI, Lockey RF (Eds), Dave Lambert Associates, Pittsburgh 2003. p.83.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Müller UR. Bee venom allergy in beekeepers and their family members. Curr Opin Allergy Clin Immunol 2005; 5:343.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mueller UR. Cardiovascular disease and anaphylaxis. Curr Opin Allergy Clin Immunol 2007; 7:337.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Toogood JH. Risk of anaphylaxis in patients receiving beta-blocker drugs. J Allergy Clin Immunol 1988; 81:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pumphrey RS. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 2000; 30:1144.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Akin C, Scott LM, Kocabas CN, et al. Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with "idiopathic" anaphylaxis. Blood 2007; 110:2331.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Haeberli G, Brönnimann M, Hunziker T, Müller U. Elevated basal serum tryptase and hymenoptera venom allergy: relation to severity of sting reactions and to safety and efficacy of venom immunotherapy. Clin Exp Allergy 2003; 33:1216.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ludolph-Hauser D, Ruëff F, Fries C, et al. Constitutively raised serum concentrations of mast-cell tryptase and severe anaphylactic reactions to Hymenoptera stings. Lancet 2001; 357:361.
          </a>
         </li>
         <li class="breakAll">
          Golden DBK. Insect allergy. In: Middleton's allergy: Principles and practice, 8th ed, Adkinson NF, Bochner B, Busse WW, et al (Eds), Elsevier (Saunders), Philadelphia 2014. p.1260.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stoevesandt J, Hain J, Kerstan A, Trautmann A. Over- and underestimated parameters in severe Hymenoptera venom-induced anaphylaxis: cardiovascular medication and absence of urticaria/angioedema. J Allergy Clin Immunol 2012; 130:698.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reisman RE. Natural history of insect sting allergy: relationship of severity of symptoms of initial sting anaphylaxis to re-sting reactions. J Allergy Clin Immunol 1992; 90:335.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vetter RS, Visscher PK, Camazine S. Mass envenomations by honey bees and wasps. West J Med 1999; 170:223.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Betten DP, Richardson WH, Tong TC, Clark RF. Massive honey bee envenomation-induced rhabdomyolysis in an adolescent. Pediatrics 2006; 117:231.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Allsopp M. The Pretoria Killer Bee. Am Bee J 1992; 132:516.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moffitt JE. Allergic reactions to insect stings and bites. South Med J 2003; 96:1073.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pinto MA, Rubink WL, Patton JC, et al. Africanization in the United States: replacement of feral European honeybees (Apis mellifera L.) by an African hybrid swarm. Genetics 2005; 170:1653.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reisman RE, Livingston A. Late-onset allergic reactions, including serum sickness, after insect stings. J Allergy Clin Immunol 1989; 84:331.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reisman RE. Unusual reactions to insect stings. Curr Opin Allergy Clin Immunol 2005; 5:355.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Quercia O, Emiliani F, Foschi FG, Stefanini GF. Unusual reaction to hymenoptera sting: a case of Schönlein-Henoch purpura. Allergy 2007; 62:333.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lichtenstein LM, Golden DB. Postscript to bee stings: delayed 'serum sickness'. Hosp Pract (Off Ed) 1983; 18:36, 40, 40A, passim.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hogendijk S, Hauser C. Wasp sting-associated cold urticaria. Allergy 1997; 52:1145.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kalogeromitros D, Gregoriou S, Papaioannou D, et al. Acquired primary cold contact urticaria after Hymenoptera sting. Clin Exp Dermatol 2004; 29:93.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wong CG, Borici-Mazi R. Delayed-onset cold anaphylaxis after hymenoptera sting. Ann Allergy Asthma Immunol 2012; 109:77.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 4091 Version 32.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="javascript:alert('بدون لینک');" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Gurlanick MW, Benton AW. Entomological aspects of insect sting allergy. In: Monograph on insect allergy, 4th ed, Levine MI, Lockey RF (Eds), Dave Lambert Associates, Pittsburgh 2003. p.11.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="javascript:alert('بدون لینک');" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Goddard J. Physician's guide to arthropods of medical importance, 4th ed, CRC Press, Boca Raton 2003.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12660058" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Ant venom immunotherapy: a double-blind, placebo-controlled, crossover trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8709689" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Removing bee stings.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18043193" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Corneal bee sting misdiagnosed as viral keratitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1806605" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Cutaneous reaction induced by retained bee stinger.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7722162" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : The natural history of exposure to the imported fire ant (Solenopsis invicta).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1257814" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : The imported fire ant: health hazard or nuisance?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19458526" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Large local reactions from stinging insects: from epidemiology to management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28007086" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Stinging insect hypersensitivity: A practice parameter update 2016.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28007086" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Stinging insect hypersensitivity: A practice parameter update 2016.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6491095" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Natural history of large local reactions from stinging insects.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6716215" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : A prospective study of the natural history of large local reactions after Hymenoptera stings in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15525723" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Clinical practice. Hypersensitivity to hymenoptera stings.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31074868" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Large local reactions to Hymenoptera stings: Outcome of re-stings in real life.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12110838" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Venom immunotherapy improves health-related quality of life in patients allergic to yellow jacket venom.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6501749" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Dermal hypersensitivity reactions to imported fire ants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16461139" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Second symposium on the definition and management of anaphylaxis: summary report--Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19506470" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Epidemiology of anaphylaxis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/78446" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : A controlled trial of immunotherapy in insect hypersensitivity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6776143" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Physiologic manifestations of human anaphylaxis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16751010" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Allergic reactions to insect stings: results from a national survey of 10,000 junior high school children in Israel.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17493502" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Insect sting anaphylaxis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18596590" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Epidemiology of insect-venom anaphylaxis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16310531" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Insect sting allergy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2098016" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : The value of immunotherapy with venom in children with allergy to insect stings.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4746790" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Studies of 400 Hymenoptera sting deaths in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3706199" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Studies in stinging insect hypersensitivity: postmortem demonstration of antivenom IgE antibody in possible sting-related sudden death.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12109787" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : An autopsy approach to bee sting-related deaths.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2739018" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Epidemiology of insect venom sensitivity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2739018" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Epidemiology of insect venom sensitivity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15985817" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Bee venom allergy in beekeepers and their family members.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17620826" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Cardiovascular disease and anaphylaxis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2892872" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Risk of anaphylaxis in patients receiving beta-blocker drugs.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10931122" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Lessons for management of anaphylaxis from a study of fatal reactions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17638853" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with "idiopathic" anaphylaxis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12956741" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Elevated basal serum tryptase and hymenoptera venom allergy: relation to severity of sting reactions and to safety and efficacy of venom immunotherapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11211002" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Constitutively raised serum concentrations of mast-cell tryptase and severe anaphylactic reactions to Hymenoptera stings.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11211002" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Constitutively raised serum concentrations of mast-cell tryptase and severe anaphylactic reactions to Hymenoptera stings.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22554708" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Over- and underestimated parameters in severe Hymenoptera venom-induced anaphylaxis: cardiovascular medication and absence of urticaria/angioedema.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1345753" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Natural history of insect sting allergy: relationship of severity of symptoms of initial sting anaphylaxis to re-sting reactions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10344177" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Mass envenomations by honey bees and wasps.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16396886" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Massive honey bee envenomation-induced rhabdomyolysis in an adolescent.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : The Pretoria Killer Bee
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14632354" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Allergic reactions to insect stings and bites.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15937139" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Africanization in the United States: replacement of feral European honeybees (Apis mellifera L.) by an African hybrid swarm.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2778239" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Late-onset allergic reactions, including serum sickness, after insect stings.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15985819" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Unusual reactions to insect stings.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17298353" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Unusual reaction to hymenoptera sting: a case of Schönlein-Henoch purpura.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6416995" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Postscript to bee stings: delayed 'serum sickness'.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9404573" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Wasp sting-associated cold urticaria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14723735" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Acquired primary cold contact urticaria after Hymenoptera sting.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22727165" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Delayed-onset cold anaphylaxis after hymenoptera sting.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
